BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention concerns an improved therapeutic regimen for the treatment of thrombolytic disorders, such as acute myocardial infarction (AMI). In particular, the present invention concerns the treatment of thrombolytic disorders, e.g. AMI
FIELD OF THE INVENTION
The present invention relates to novel modified corin molecules, or fragments or derivatives thereof, comprising a substitute activation sequence.
BACKGROUND
Serine proteases are essential for a variety of biological processes, including food digestion, hormone processing,